Latest stories on BAYRY
Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court
Reuters38 · neutralgeneral
Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court
Yahoo Finance48 · neutralgeneral
Bayer Expands Real World Surveillance for Darolutamide in Indian Prostate Cancer Market
TipRanks56 · neutralproduct/pr
Bayer granted accelerated approval for Hyrnuo by FDA
The Fly73 · bullishproduct/pr
Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment
MarketWatch73 · bullishproduct/pr
FDA grants accelerated approval to added indication for Bayer’s sevabertinib
The Fly73 · bullishproduct/pr
BAYER INITIATES PHASE II STUDY OF INVESTIGATIONAL GIRK4 INHIBITOR IN PATIENTS WITH ATRIAL FIBRILLATION
StockTitan59 · neutralproduct/pr
Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial
TipRanks67 · bullishproduct/pr
Bayer’s experimental PET tracer shows accuracy in Phase 3 cardiac amyloidosis
Seeking Alpha63 · neutralproduct/pr
Bayer announces presentation of results from Phase III REVEAL study
The Fly50 · neutralgeneral
Bayer’s AskBio completes enrollment in Phase 2 heart failure gene therapy trial
Seeking Alpha63 · neutralproduct/pr
Bayer to present data from cardiovascular, kidney, stroke programs at ESC 2026
The Fly59 · neutralproduct/pr
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026
StockTitan67 · bullishproduct/pr
Bayer Aktiengesellschaft 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Bayer granted court delay to September for Roundup settlement hearing
Seeking Alpha42 · neutralgeneral
Bayer Price Target Raised To Eur 61 From Eur 50 At Jpmorgan
The Fly63 · neutralanalyst
Bayer’s Rivaroxaban PAD Study Reaches Completion: What Investors Should Watch Next
TipRanks55 · neutralgeneral
Bayer seeks short delay to $7.25 billion Roundup settlement hearing
Reuters34 · bearishgeneral
Bayer CEO Rules out Group Breakup for Now — Update
Morningstar54 · neutralgeneral
Bayer Swings to Net Profit on Smaller Litigation Charges
WSJ Business63 · neutralearnings
Bayer Refines Nurandociguat Tablet in New Phase 1 Study, Keeping CKD Pipeline on Track
TipRanks59 · neutralproduct/pr
Bayer gets €3 billion in Apollo deal for contraceptives unit
Reuters58 · neutralm&a